Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad
US9220719B2 · kind B2 · utility
2Cited by
1References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2013 |
| Grant date | Dec 29, 2015 |
| Priority date | — |
| Expiry date | Jul 18, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P33/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a single-dose oral formulation of spinosad for the extended control of a C. felis infestation on a cat at a predictable dose of spinosad that is suitable for administration once every 30 days (i.e., one month). The invention also provides methods of using the formulation of spinosad.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.